Summary:
This study is investigating the safety, efficacy, and absoprtion of an investigational oral medication for moderate to severe atopic dermatitis, also know as eczema.
Qualified Participants Must:
• Be between 18-75 years old
•
Have moderate to severe eczema
•
Have used a topical medication within the last 6
•months to treat their eczema
Qualified Participants May Receive:
Study realted care from a board-certified dermatologist